Potential Role of Zinc Supplementation in Prophylaxis and Treatment of COVID-19

Overview

Journal Med Hypotheses

Specialty General Medicine

Date 2020 Jun 9

PMID 32512490

Citations 76

Authors

Amit Kumar

Yuichi Kubota

Mikhail Chernov

Hidetoshi Kasuya

Affiliations

Soon will be listed here.

Abstract

Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the largest current health challenge for the society. At the moment, the therapeutic strategies to deal with this disease are only supportive. It is well known that zinc (Zn) possesses a variety of direct and indirect antiviral properties, which are realized through different mechanisms. Administration of Zn supplement has a potential to enhance antiviral immunity, both innate and humoral, and to restore depleted immune cell function or to improve normal immune cell function, in particular in immunocompromised or elderly patients. Zn may also act in a synergistic manner when co-administered with the standard antiviral therapy, as was demonstrated in patients with hepatitis C, HIV, and SARS-CoV-1. Effectiveness of Zn against a number of viral species is mainly realized through the physical processes, such as virus attachment, infection, and uncoating. Zn may also protect or stabilize the cell membrane which could contribute to blocking of the virus entry into the cell. On the other hand, it was demonstrated that Zn may inhibit viral replication by alteration of the proteolytic processing of replicase polyproteins and RNA-dependent RNA polymerase (RdRp) in rhinoviruses, HCV, and influenza virus, and diminish the RNA-synthesizing activity of nidoviruses, for which SARS-CoV-2 belongs. Therefore, it may be hypothesized that Zn supplementation may be of potential benefit for prophylaxis and treatment of COVID-19.

Citing Articles

Patterns of Dietary Supplement Use during the COVID-19 Pandemic in Poland: Focus on Vitamin D and Magnesium.

Grosman-Dziewiszek P, Jeskowiak-Kossakowska I, Szelag A, Wiatrak B Nutrients. 2024; 16(19).

PMID: 39408194 PMC: 11478616. DOI: 10.3390/nu16193225.

Strategies and bibliometric analysis of legumes biofortification to address malnutrition.

Altaf M, Liaqat W, Jamil A, Jan M, Baloch F, Barutcular C Planta. 2024; 260(4):85.

PMID: 39227398 DOI: 10.1007/s00425-024-04504-0.

Boosting immunity: synergistic antiviral effects of luteolin, vitamin C, magnesium and zinc against SARS-CoV-2 3CLpro.

Ferreira J, Fadl S, Cardoso T, Andrade B, Melo T, Silva E Biosci Rep. 2024; 44(8).

PMID: 39045772 PMC: 11327220. DOI: 10.1042/BSR20240617.

Comparison of vascular cell adhesion molecule 1 (VCAM-1) during pregnancy, after placental detachment and during puerperium between normal and pregnancy with COVID-19.

Pasaribu H, Lumbanraja S, Varenni W, Enitan S Narra J. 2024; 3(3):e413.

PMID: 38450333 PMC: 10914036. DOI: 10.52225/narra.v3i3.413.

Multifunctional role of zinc in human health: an update.

Kiouri D, Tsoupra E, Peana M, Perlepes S, Stefanidou M, Chasapis C EXCLI J. 2023; 22:809-827.

PMID: 37780941 PMC: 10539547. DOI: 10.17179/excli2023-6335.

References

Cakman I, Kirchner H, Rink L . Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res. 1997; 17(8):469-72. DOI: 10.1089/jir.1997.17.469. View

Saha A, Hadden E, Hadden J . Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo. Int J Immunopharmacol. 1995; 17(9):729-33. DOI: 10.1016/0192-0561(95)00061-6. View

Himoto T, Masaki T . Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease. Nutrients. 2018; 10(1). PMC: 5793316. DOI: 10.3390/nu10010088. View

Hung M, Gibbs C, Tsiang M . Biochemical characterization of rhinovirus RNA-dependent RNA polymerase. Antiviral Res. 2002; 56(2):99-114. DOI: 10.1016/s0166-3542(02)00101-8. View

Te Velthuis A, van den Worm S, Sims A, Baric R, Snijder E, van Hemert M . Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010; 6(11):e1001176. PMC: 2973827. DOI: 10.1371/journal.ppat.1001176. View

Brautigan D, Bornstein P, Gallis B . Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. J Biol Chem. 1981; 256(13):6519-22. View

Perlman S, Netland J . Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009; 7(6):439-50. PMC: 2830095. DOI: 10.1038/nrmicro2147. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Novick S, Godfrey J, POLLACK R, Wilder H . Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants. Med Hypotheses. 1997; 49(4):347-57. DOI: 10.1016/s0306-9877(97)90201-2. View

10.

Asdamongkol N, Phanachet P, Sungkanuparph S . Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy. Jpn J Infect Dis. 2013; 66(6):469-74. DOI: 10.7883/yoken.66.469. View

11.

Schoggins J, Wilson S, Panis M, Murphy M, Jones C, Bieniasz P . A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011; 472(7344):481-5. PMC: 3409588. DOI: 10.1038/nature09907. View

12.

Shishkov S, Varadinova T, Bontchev P, Nachev C, Michailova E . Complexes of zinc with picolinic and aspartic acids inactivate free varicella-zoster virions. Met Based Drugs. 1996; 3(1):11-4. PMC: 2364995. DOI: 10.1155/MBD.1996.11. View

13.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

14.

Perry D, Smyth M, Stennicke H, Salvesen G, Duriez P, Poirier G . Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem. 1997; 272(30):18530-3. DOI: 10.1074/jbc.272.30.18530. View

15.

Ferrari E, Fang J, Baroudy B, Lau J, Hong Z . Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol. 1999; 73(2):1649-54. PMC: 103993. DOI: 10.1128/JVI.73.2.1649-1654.1999. View

16.

Lanke K, Krenn B, Melchers W, Seipelt J, van Kuppeveld F . PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol. 2007; 88(Pt 4):1206-1217. DOI: 10.1099/vir.0.82634-0. View

17.

Denison M, Zoltick P, Hughes S, Giangreco B, Olson A, Perlman S . Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events. Virology. 1992; 189(1):274-84. PMC: 7130892. DOI: 10.1016/0042-6822(92)90703-r. View

18.

Liu C, Kielian M . Identification of a specific region in the e1 fusion protein involved in zinc inhibition of semliki forest virus fusion. J Virol. 2012; 86(7):3588-94. PMC: 3302541. DOI: 10.1128/JVI.07115-11. View

19.

Gorbalenya A, Enjuanes L, Ziebuhr J, Snijder E . Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006; 117(1):17-37. PMC: 7114179. DOI: 10.1016/j.virusres.2006.01.017. View

20.

Novick S, Godfrey J, Godfrey N, Wilder H . How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. Med Hypotheses. 1996; 46(3):295-302. DOI: 10.1016/s0306-9877(96)90259-5. View